[HTML][HTML] Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency
HM Isa, MS Mohamed, AM Mohamed… - Korean journal of …, 2017 - ncbi.nlm.nih.gov
Purpose This study aimed to determine the prevalence of glucose-6-phosphate
dehydrogenase (G6PD) deficiency among infants with neonatal indirect hyperbilirubinemia (NIH); …
dehydrogenase (G6PD) deficiency among infants with neonatal indirect hyperbilirubinemia (NIH); …
Efficacy and safety of endoscopic esophageal dilatation in pediatric patients with esophageal strictures
…, KA Hasan, HY Ahmed, AM Mohamed - International Journal of …, 2021 - Wiley Online Library
Background and Objectives. Benign strictures are the main cause of esophageal strictures
in children. They can be managed by different modalities but endoscopic dilatation is the …
in children. They can be managed by different modalities but endoscopic dilatation is the …
[HTML][HTML] Growth assessment and risk factors of malnutrition in children with cystic fibrosis
HM Isa, LF Al-Ali, AM Mohamed - Saudi Medical Journal, 2016 - ncbi.nlm.nih.gov
Objectives: To evaluate the nutritional status, to screen for the presence of malnutrition, and
to study the possible risk factors associated with malnutrition in patients with cystic fibrosis (…
to study the possible risk factors associated with malnutrition in patients with cystic fibrosis (…
[HTML][HTML] Intestinal lymphangiectasia in children: A favorable response to dietary modifications
HM Isa, GG Al-Arayedh, AM Mohamed - Saudi medical journal, 2016 - ncbi.nlm.nih.gov
Intestinal lymphangiectasia (IL) is a rare disease characterized by dilatation of intestinal
lymphatics. It can be classified as primary or secondary according to the underlying etiology. …
lymphatics. It can be classified as primary or secondary according to the underlying etiology. …
[HTML][HTML] Pediatric Crohn's disease in Bahrain
HM Isa, AM Mohamed, HE Al-Jowder… - Oman Medical …, 2018 - ncbi.nlm.nih.gov
Objectives Our study aimed to report the epidemiology, clinical presentations, diagnostic
and therapeutic approaches, and outcomes of Crohn’s disease (CD) in pediatric patients in …
and therapeutic approaches, and outcomes of Crohn’s disease (CD) in pediatric patients in …
[HTML][HTML] Celiac disease in children: increasing prevalence and changing clinical presentations
…, E Farid, JJ Makhlooq, AM Mohamed… - Clinical and …, 2021 - ncbi.nlm.nih.gov
Background Celiac disease (CD) is a chronic autoimmune enteropathy. It results from genetic
predisposition and exposure to gluten-containing food. The prevalence and presentation …
predisposition and exposure to gluten-containing food. The prevalence and presentation …
[PDF][PDF] IMMUNOHISTOCHEMICAL EXPRESSION OF FORKHEAD BOX (FOX) A1 IN EPITHELIAL OVARIAN CANCER
Background: Ovarian cancer (OC) ranks as the fifth leading cause of malignancy-associated
mortality in females. Purpose: This study aims to evaluate the association between A1 …
mortality in females. Purpose: This study aims to evaluate the association between A1 …
[PDF][PDF] Abetalipoproteinemia: three case reports, a novel microsomal triglyceride transfer protein gene mutation and a literature review
HM Isa, AM Mohamed - J Clin Case Rep, 2016 - academia.edu
Abetalipoproteinemia (ABL, OMIM 200100) is a very rare metabolic disease with reported
prevalence of less than one case per 100,000. It is an autosomal recessive disease resulting …
prevalence of less than one case per 100,000. It is an autosomal recessive disease resulting …
Spectrophotometric determination of two N-(4-quinolyl) anthranilic acid derivative (glafenine and floctafenine)
…, FM El Tarras, ZA El Sherif, AO Mohamed - … of pharmaceutical and …, 2000 - Elsevier
Spectrophotometric methods were developed for the determination of glafenine and
floctafenine. The first method depends upon the determination of glafenine in raw material and …
floctafenine. The first method depends upon the determination of glafenine in raw material and …
[HTML][HTML] Safety and efficacy of COVID-19 prime-boost vaccinations: homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed …
…, J Jawad, P Wasif, B Alsaffar, E Alalawi, AM Mohamed… - Vaccine, 2023 - Elsevier
Background Booster vaccine doses against SARS-CoV-2 have been advocated to address
evidence of waning immunity, breakthrough infection, and the emergence of immune-…
evidence of waning immunity, breakthrough infection, and the emergence of immune-…